Arca Biopharma | ABIO - Ebitda


Arca Biopharma reported $-25.07M in EBITDA for its fiscal quarter ending in March of 2025.





Ebitda Change Date
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Amgen USD 5.8B 1.25B Sep/2026
Arca Biopharma USD -25.07M 5.23M Mar/2025
Biogen USD 450.8M 198.9M Jun/2026
Brainstorm Cell Therapeutics USD -3.04M 99K Mar/2025
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Capricor Therapeutics USD -27.23M 2.66M Jun/2025
Cipla INR 13.88B 154.2M Sep/2026
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -8.84M 180K Jun/2026
CSL USD 3.13B 1.17B Dec/2025
Cytokinetics USD -160.3M 9.02M Jun/2026
Daiichi Sankyo JPY 116.06B 14.46B Jun/2026
Gilead Sciences USD -9.31B 12.82B Jun/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Grifols EUR 482.04M 7.04M Sep/2025
Laboratory Of America USD 674.3M 93.4M Sep/2026
Myriad Genetics USD 14.3M 4M Dec/2025
Otsuka Holdings JPY 174.82B 14.19B Sep/2026
Pfizer USD 6.36B 350M Sep/2026
United Therapeutics USD 334.2M 20.8M Sep/2026